Pharma IQ Glossary: Bioreactor

Biotech sees swift growth in job openings despite the shrinking level of life sciences vacancies in the UK.

The need for more speed to the market in biomanufacturing is fueling the acceptance and implementation of single use systems despite their complications

After surveying over 1200 life science leaders, this research captures the shared role of quality and manufacturing across enterprise and operational domains in medicine production.

Top representatives from industry associations USP, BPOG and BPSA discuss the protocols that address the use of disposable products and single use systems in biomanufacturing.

Ahead of the Cell and Gene Therapy Manufacturing conference, Pharma IQ examines the top 10 challenges that complicate the route to manufacturing commercial cell and gene products.

Limitations in compatibility between certain single use system devices for biomanufacturing is a challenge that has raged for quite some time. A number of experts discuss the latest on the matter and...

This heatmap scans the cell and gene manufacturing activity occurring across Europe on the road to commercializing these therapies.

Strong Growth is expected in the Overall Upstream Process market Upstream process is vital in the manufacturing of biopharmaceuticals to have control over growth conditions and nutrients which eventu...

Single use technologies are strong change agents in biopharma manufacturing.  Disposable devices emerge once again as a top new technology of interest among the 352 surveyed biomanufacturers in B...

With speed and flexibility also at the top of the priority list when it comes to biomanufacturing, it’s clear why single use systems have seen such growth in recent years. However, streamlining your b...